Hypogonadism epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Age) |
|||
| Line 10: | Line 10: | ||
*The prevalence of androgen deficiency ranges from a low of 6,000 per 100,000 persons aging 40 years to a high of 12,000 per 100,000 persons aging 70 years.<ref name="pmid15579737">{{cite journal| author=Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM et al.| title=Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. | journal=J Clin Endocrinol Metab | year= 2004 | volume= 89 | issue= 12 | pages= 5920-6 | pmid=15579737 | doi=10.1210/jc.2003-031719 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15579737 }} </ref> | *The prevalence of androgen deficiency ranges from a low of 6,000 per 100,000 persons aging 40 years to a high of 12,000 per 100,000 persons aging 70 years.<ref name="pmid15579737">{{cite journal| author=Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM et al.| title=Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. | journal=J Clin Endocrinol Metab | year= 2004 | volume= 89 | issue= 12 | pages= 5920-6 | pmid=15579737 | doi=10.1210/jc.2003-031719 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15579737 }} </ref> | ||
*There is no sufficient prevelance results for hypogonadism in women. | *There is no sufficient prevelance results for hypogonadism in women. | ||
===Incidence=== | |||
The incidence of hypogonadism is 1230 per 100,000 persons.<ref name="pmid15579737">{{cite journal| author=Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM et al.| title=Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. | journal=J Clin Endocrinol Metab | year= 2004 | volume= 89 | issue= 12 | pages= 5920-6 | pmid=15579737 | doi=10.1210/jc.2003-031719 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15579737 }} </ref> | |||
===Gender=== | ===Gender=== | ||
Revision as of 12:46, 17 July 2017
|
Hypogonadism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypogonadism epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hypogonadism epidemiology and demographics |
|
Risk calculators and risk factors for Hypogonadism epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Epidemiology and demographics
Prevelance
- The prevalence of hypogonadism in men is 38,700 per 100,000 persons aging 45 years.[1]
- The prevalence of androgen deficiency ranges from a low of 6,000 per 100,000 persons aging 40 years to a high of 12,000 per 100,000 persons aging 70 years.[2]
- There is no sufficient prevelance results for hypogonadism in women.
Incidence
The incidence of hypogonadism is 1230 per 100,000 persons.[2]
Gender
Hypogonadism is more common in the male than females.
Age
The prevalence of hypogonadism increases with age.
Race
There is racial predilection of hypogonadism.
References
- ↑ Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C (2006). "Prevalence of hypogonadism in males aged at least 45 years: the HIM study". Int J Clin Pract. 60 (7): 762–9. doi:10.1111/j.1742-1241.2006.00992.x. PMC 1569444. PMID 16846397.
- ↑ 2.0 2.1 Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM; et al. (2004). "Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study". J Clin Endocrinol Metab. 89 (12): 5920–6. doi:10.1210/jc.2003-031719. PMID 15579737.